Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:public_company
|
| gptkbp:CEO |
gptkb:Kevin_Sayer
|
| gptkbp:component |
gptkb:NASDAQ-100
gptkb:S&P_500 |
| gptkbp:country |
gptkb:United_States
|
| gptkbp:currency |
gptkb:USD
|
| gptkbp:CUSIP |
252131107
|
| gptkbp:foundedBy |
gptkb:Scott_Glenn
|
| gptkbp:foundedYear |
1999
|
| gptkbp:headquartersLocation |
gptkb:San_Diego,_California,_United_States
|
| gptkbp:heldBy |
US2521311074
|
| https://www.w3.org/2000/01/rdf-schema#label |
NASDAQ:DXCM
|
| gptkbp:industry |
Medical Devices
|
| gptkbp:marketCap |
~$40 billion (2024)
|
| gptkbp:numberOfEmployees |
~8000 (2023)
|
| gptkbp:product |
gptkb:Dexcom_G6
gptkb:Dexcom_G7 gptkb:Continuous_Glucose_Monitoring_Systems |
| gptkbp:sector |
gptkb:insurance
|
| gptkbp:stockExchange |
gptkb:NASDAQ
|
| gptkbp:stockSymbol |
gptkb:DXCM
gptkb:Dexcom,_Inc. |
| gptkbp:website |
https://www.dexcom.com/
|
| gptkbp:bfsParent |
gptkb:Dexcom
|
| gptkbp:bfsLayer |
6
|